Home › Geographic Atrophy › Texas › San Antonio
Geographic Atrophy clinical trials in San Antonio, TX
5 studies for Geographic Atrophy are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RecruitingPhase 2/3
- Retina Associates Of South Texas P A, San Antonio
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
RecruitingPhase 1/2
- Retinal Consultants of Texas - San Antonio- Site Number : 8400012, San Antonio
A Study in Adults With Geographic Atrophy
RecruitingPhase 2
- Retina Consultants of Texas, Schertz · 16 mi away
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- Medical Center Ophthalmology Associates, San Antonio
- Retina Associates of South Texas, San Antonio
- Retina Consultants of Texas, San Antonio
- and 1 more
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
RecruitingPhase 2
- Medical Center Ophthalmology Associates, LLP, San Antonio
- Retina Associates of South Texas, PA, San Antonio
- Retina Consultants of Texas, San Antonio
Geographic Atrophy trials in other cities
- Dallas, TX8 studies
- Reno, NV8 studies
- Austin, TX7 studies
- Santa Monica, CA7 studies
- Cleveland, OH6 studies
- Houston, TX6 studies
- The Woodlands, TX6 studies
- Naperville, IL6 studies
- Baltimore, MD6 studies
- Spokane, WA5 studies
- Erie, PA5 studies
- Washington, DC5 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer59 studies
- Colorectal Cancer46 studies
- Breast Cancer46 studies
- Metastatic Cancer44 studies
- Cancer (all types)41 studies
- Obesity40 studies
- Type 2 Diabetes37 studies
- Overweight34 studies
- Ovarian Cancer31 studies
- Pancreatic Cancer31 studies
- Prostate Cancer28 studies
- Endometrial Cancer27 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.